Dr.ย Yeon Heeย Park
M.D., Ph.D.
Professor, Department of Hematology-Oncology
corporate_fareSamsung Medical Center, Seoul
Yeon Hee Park
M.D., Ph.D.
Prof. Yeon Hee Park is a Professor in the Department of Hematology-Oncology at Samsung Medical Center and Sungkyunkwan University School of Medicine in Seoul, South Korea. She is a specialist in breast cancer medical oncology, with over 25 years of clinical and academic experience in the systemic treatment of breast cancer. Samsung Medical Center lists her clinical expertise as breast cancer and identifies her specialty group as the Breast Cancer Centre.
Prof. Park's career has centred on the management of advanced and metastatic breast cancer, with particular focus on hormone receptor-positive, HER2-positive, and triple-negative subtypes, including breast cancer in premenopausal women. She has held successive leadership roles at Samsung Medical Center, serving as Secretary of the Breast Cancer Centre, Director of the Breast Cancer Centre from 2017 to 2021, and currently Director of the Clinical Trial Centre since 2021. Her postdoctoral training was completed at UCSD Cancer Center and the Sidney Kimmel Cancer Center in San Diego. Sungkyunkwan University attributes 389 research outputs, an h-index of 63, and more than 26,000 citations to her academic profile, placing her among the most-cited breast cancer researchers at the institution.
Samsung Medical Center provides English-language appointment and international patient contact information. CancerFax can coordinate medical record review and consultation support for international patients seeking an opinion from Prof. Park, subject to hospital availability and case acceptance.
Why Consider Prof. Yeon Hee Park?
Prof. Park combines focused clinical expertise in breast cancer with one of the most active research profiles in Korean oncology. Her dual role as a treating oncologist and Director of the Clinical Trial Centre at Samsung Medical Center offers patients access to both established and investigational treatment approaches.
Areas of Specialisation
Prof. Park's clinical and research focus is breast cancer medical oncology across all major molecular subtypes, with particular expertise in advanced and metastatic disease.
Prof. Yeon Hee Park specialises in the systemic treatment of breast cancer, covering hormone receptor-positive, HER2-positive, triple-negative, and young-age breast cancer. Her clinical expertise is complemented by an extensive research programme in modern breast cancer therapeutics.
Hormone Receptor-Positive Breast Cancer
Endocrine therapy and CDK4/6 inhibitor-based strategies for premenopausal and postmenopausal patients with HR-positive, HER2-negative disease.
- arrow_rightAromatase inhibitor-based regimens for postmenopausal patients
- arrow_rightGnRH agonist strategies for ovarian function suppression in premenopausal disease
- arrow_rightExemestane plus GnRH agonist combinations in metastatic disease
- arrow_rightPalbociclib-based combination treatment planning for eligible patients
- arrow_rightPremenopausal HR-positive metastatic breast cancer treatment, including Young-PEARL study protocols
- arrow_rightBiomarker-informed treatment selection for advanced disease
HER2-Positive and Triple-Negative Breast Cancer
Anti-HER2 therapy, antibody-drug conjugates, immunotherapy, and chemotherapy for HER2-positive and triple-negative subtypes.
- arrow_rightTrastuzumab deruxtecan and other HER2-targeted agent research and clinical application
- arrow_rightSacituzumab govitecan research in breast cancer
- arrow_rightTreatment planning for HER2-low metastatic breast cancer where applicable
- arrow_rightPembrolizumab-based treatment in triple-negative breast cancer
- arrow_rightChemotherapy protocols for advanced triple-negative disease
- arrow_rightCapivasertib plus paclitaxel and other investigational approaches in eligible patients
Young-Age and Premenopausal Breast Cancer
Dedicated focus on the unique clinical and treatment considerations for younger women and premenopausal patients with breast cancer.
- arrow_rightOvarian function suppression in combination with systemic therapy
- arrow_rightTreatment strategies for premenopausal HR-positive metastatic disease
- arrow_rightBRCA-associated breast cancer management research
Procedures Performed
Clinical treatment services and research-integrated care approaches for breast cancer at Samsung Medical Center
Prof. Park provides systemic oncology care for breast cancer patients, including chemotherapy, endocrine therapy, CDK4/6 inhibitor-based regimens, anti-HER2 therapy, and participation in clinical trials. Her role as Director of the Clinical Trial Centre means eligible patients may be considered for investigational treatment options.
Medical Oncology โ Breast Cancer
Medical OncologySystemic treatment planning and administration for all major breast cancer subtypes.
Targeted Therapy
Targeted TherapyBiomarker-guided treatment approaches using modern targeted and precision oncology agents.
Clinical Trial Evaluation
Complex DiseaseEvaluation for clinical trial eligibility and investigational treatment access at Samsung Medical Center's Clinical Trial Centre.
Second Opinion
Second OpinionReview of pathology, imaging, prior treatment history, and molecular findings for second-opinion consultations in breast cancer.
Research & Publications
Peer-reviewed contributions and clinical trial leadership in breast cancer oncology
Prof. Yeon Hee Park is one of the most prolific breast cancer researchers in South Korea. Sungkyunkwan University attributes 389 research outputs to her profile, with an h-index of 63 and more than 26,000 citations. Her research spans the full spectrum of modern breast cancer treatment, from endocrine therapy and CDK4/6 inhibitors to antibody-drug conjugates and genomic breast cancer biology.
Prof. Park's full publication list is available on PubMed and via her Sungkyunkwan University research profile (ORCID: 0000-0003-4156-9212). A more detailed list may be provided on request.
Education & Training
Prof. Park completed her medical degree at Ewha Women's University College of Medicine and her postgraduate training at Kyung Hee University and Korea Cancer Center Hospital. She undertook postdoctoral fellowships at UCSD Cancer Center and the Sidney Kimmel Cancer Center in San Diego, USA.
Clinical Experience
Prof. Park began her clinical career at Seoul Adventist Hospital and Korea Cancer Center Hospital before completing postdoctoral research in the United States. She joined Samsung Medical Center and Sungkyunkwan University School of Medicine in 2008, progressing to full Professor in 2014. She has held successive leadership roles in breast cancer care and clinical research, and currently serves as Director of the Clinical Trial Centre.
Languages & International
Prof. Park consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting at Samsung Medical Center.
CancerFax can coordinate professional medical interpreter support for international patients where required.
How CancerFax Helps You Access Dr. Yeon Hee Park
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Yeon Hee Park's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Yeon Hee Park's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Yeon Hee Park before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Yeon Hee Park's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Yeon Hee Park's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Yeon Hee Park's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Yeon Hee Park
Prof. Yeon Hee Park specialises in breast cancer medical oncology within the Department of Hematology-Oncology at Samsung Medical Center, Seoul. Samsung Medical Center lists her specialty group as the Breast Cancer Centre and her clinical expertise as breast cancer.
Prof. Park's verified clinical focus covers hormone receptor-positive breast cancer (including HR-positive, HER2-negative disease), HER2-positive breast cancer, triple-negative breast cancer, and premenopausal or young-age breast cancer. She has particular expertise in advanced and metastatic breast cancer management.
Samsung Medical Center maintains an English-language international patient services infrastructure and lists international appointment contact details on its English-language doctor profiles. CancerFax can assist international patients in organising medical records, preparing structured case summaries, and coordinating the consultation process with the hospital, subject to availability and case acceptance.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare a structured case summary, and coordinate the next steps with Samsung Medical Center on your behalf, subject to the hospital's availability and case review process.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, molecular findings, and relevant test results. The final consultation format, timeline, and availability depend on Samsung Medical Center's appointment process. CancerFax will coordinate the submission and follow up on your behalf.
Yes. Prof. Park currently serves as Director of the Clinical Trial Centre at Samsung Medical Center. She is the principal investigator of the Young-PEARL study, a clinical trial evaluating palbociclib plus exemestane with GnRH agonist versus capecitabine in premenopausal HR-positive, HER2-negative metastatic breast cancer (NCT02592746). Updated survival results from this study were presented at the 2024 ASCO Annual Meeting.
Connect with Yeon Hee Park Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.